1. Introduction
1.1. Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Healthcare Contract Manufacturing Outsourcing Market Analysis, by Services
5.1. Introduction
5.2. Pharmaceutical CMO
5.2.1. Active Pharmaceutical Ingredients (API) Manufacturing
5.2.2. Final Dose Formulation (FDF) Manufacturing
5.2.2.1. Injectable Dose Formulations
5.2.2.2. Solid Dose Formulations
5.2.2.3. Semi-solid Dose Formulations
5.2.2.4. Liquid Dose Formulations
5.2.3. Packaging
5.3. Medical Device CMO
5.3.1. Design Outsourcing
5.3.2. Device Manufacturing
5.3.3. Final Goods Assembly
6. Healthcare Contract Manufacturing Outsourcing Market Analysis, by Type
6.1. Introduction
6.2. Sterile
6.3. Non-sterile
7. Healthcare Contract Manufacturing Outsourcing Market Analysis, by Geography
7.1. Introduction
7.2. North America
7.2.1. United States
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. UK
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. United Arab Emirates
7.5.3. Israel
7.5.4. Others
7.6. Asia Pacific
7.6.1. Japan
7.6.2. China
7.6.3. India
7.6.4. South Korea
7.6.5. Taiwan
7.6.6. Thailand
7.6.7. Indonesia
7.6.8. Others
8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. Company Profiles
9.1. Jubilant Pharma Limited
9.2. Pfizer Inc.
9.3. Lonza Group
9.4. AGC Biologics
9.5. Recipharm AB
9.6. Catalent, Inc.
9.7. The Aenova Group
9.8. Baxter
9.9. Boehringer Ingelheim International GmbH
9.10. DPx Holdings
List of Figures
List of Tables